| Rebecca Ihlenfeld, | |
|
2203 National Rd, Wheeling, WV 26003-5203 | |
| (304) 243-0300 | |
| (304) 243-0328 |
| Full Name | Rebecca Ihlenfeld |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2203 National Rd, Wheeling, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306179023 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 8815 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Ihlenfeld, 2203 National Rd, Wheeling, WV 26003-5203 Ph: (304) 243-0300 | Rebecca Ihlenfeld, 2203 National Rd, Wheeling, WV 26003-5203 Ph: (304) 243-0300 |
News Archive
In the framework of this year's round of the European Research Council's (ERC) competition for outstanding researchers, Heidelberg University has totted up a remarkable score.
One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) experienced greater cell loss overall compared to those who underwent penetrating keratoplasty (PKP), according to a new analysis of data collected from the Cornea Donor Study (CDS) Investigator Group's 2008 Specular Microscopy Ancillary Study (SMAS). However, the study, published in the March issue of Ophthalmology, showed that cell loss in DSAEK patients plateaued more quickly than in those who underwent PKP.
Keryx Biopharmaceuticals, Inc. today announced data presented for the first time at the 52nd Annual Meeting of the American Society of Hematology showing promising clinical activity, safety and tolerability of perifosine in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). KRX-0401 (perifosine) is the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway.
The Kenyatta National Hospital Ethics and Research Board recently approved the first human clinical trial in Kenya of an herbal product to treat HIV/AIDS, Kenya's Nation reports.
Chembio Diagnostics, Inc., which develops, manufactures, markets and licenses point-of-care diagnostic tests, has agreed to provide over 2,000 PrimaTB STAT-PAK tuberculosis (TB) testing kits which are approved for use in Macaques to the Orangutan Conservancy (OC) to support the organization's continued drive to raise the level of veterinary care at orangutan rehabilitation centers.
› Verified 5 days ago
Molly E. Fisher, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1 Medical Park, Wheeling, WV 26003 Phone: 304-243-3000 Fax: 304-243-3060 | |
Ms. Joellen Ruckman, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 National Rd, Wheeling, WV 26003 Phone: 304-242-1390 Fax: 304-243-5880 | |
Mrs. Carol Ann Sabatino, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 91 Zane St, Wheeling, WV 26003 Phone: 304-243-0366 | |
Tracy Michele Wood, M.A.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1007 Market St, Wheeling, WV 26003 Phone: 304-242-6722 | |
Martha L Hon, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 National Rd, Wheeling, WV 26003 Phone: 304-242-1390 Fax: 304-243-5880 | |
George Earl Lendon, MA-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Eoff St, Wheeling, WV 26003 Phone: 740-633-4737 | |
Jennifer L. Linzy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2203 National Rd, Wheeling, WV 26003 Phone: 304-243-0300 Fax: 304-243-0328 |